Talazoparib
Brand name: Talzenna
Talazoparib comes in 14 pill versions in our database, in 7 strengths, from 3 manufacturers. Check the imprint to tell them apart.
Talazoparib pill images
0.1 mg 3 pills
- Pfizer TLZ 01 Talazoparib 0.1 mg White, capsule, 14 mm Used for breast cancer
- TLZ 010 Talazoparib 0.1 mg Red, oval, 9 mm Used for breast cancer
- Pfizer TLZ 0.1 Talazoparib Tosylate 0.1 mg White, capsule Used for breast cancer
0.5 mg 2 pills
- Pfizer TLZ 05 Talazoparib 0.5 mg Pink & white, capsule, 14 mm Used for breast cancer
- TLZ 050 Talazoparib 0.5 mg Orange, capsule, 17 mm Used for breast cancer
0.25 mg 3 pills
- Pfizer TLZ 025 Talazoparib 0.25 mg White, capsule, 14 mm Used for breast cancer
- TLZ 025 Talazoparib 0.25 mg Yellow, capsule, 11 mm Used for breast cancer
- Pfizer TLZ 0.25 Talazoparib Tosylate 0.25 mg White, capsule Used for breast cancer
0.35 mg 2 pills
- Pfizer TLZ 035 Talazoparib 0.35 mg White, capsule, 14 mm Used for breast cancer
- TLZ 035 Talazoparib 0.35 mg Pink, capsule, 14 mm Used for breast cancer
0.75 mg 2 pills
- Pfizer TLZ 075 Talazoparib 0.75 mg Orange & white, capsule, 14 mm Used for breast cancer
- TLZ 075 Talazoparib 0.75 mg Red, capsule, 19 mm Used for breast cancer
1 mg 1 pill
1.0 mg 1 pill
What is Talazoparib used for?
Talazoparib is used for breast cancer.
- Medicine type
- Poly(adp-ribose) polymerase inhibitor
Official uses from the US prescribing label
BRCA-mutated (gBRCAm) HER2-negative Locally Advanced or Metastatic Breast Cancer
TALZENNA is indicated as a single agent for the treatment of adult patients with deleterious or suspected deleterious germline breast cancer susceptibility gene (BRCA)-mutated (gBRCAm) human epidermal growth factor receptor 2 (HER2)-negative locally advanced or metastatic breast cancer. Select patients for therapy based on an FDA-approved companion diagnostic for TALZENNA.
HRR Gene-mutated Metastatic Castration-Resistant Prostate Cancer (mCRPC)
TALZENNA is indicated in combination with enzalutamide for the treatment of adult patients with homologous recombination repair (HRR) gene-mutated metastatic castration-resistant prostate cancer (mCRPC).
From the FDA-approved label on DailyMed (published Jun 03, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.